|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications:A case series显示文摘Fecal microbiota transplantation(FMT) is effective in recurrent Clostridium difficile infection(r CDI). Knowledge of the safety and efficacy of FMT treatment in immune deficient patients is scarce. FMT has been suggested as a potential method for an increasing number of new indications besides r CDI. Among our FMT-treated r CDI patients, we reviewed those with major comorbidities: two human immunodeficiency virus patients, six haemodialysis patients, two kidney transplant patients, two liver transplant patients and a patient with chronic lymphatic leukaemia. We also reviewed those treated with FMT for indications other than r CDI: Salmonella carriage(two patients), trimethylaminuria(two patients), small intestinal bacterial overgrowth(SIBO;one patient), and lymphocytic colitis(one patient), as well as a common variable immunodeficiency patient with chronic norovirus infection and ESBL-producing Escherichia coli(E. coli) carriage. Of the thirteen r CDI patients treated with FMT, eleven cleared the CDI. The observed adverse events were not directly attributable to FMT. Concerning the special indications, both Salmonellas and ESBL-producing E. coli were eradicated. One trimethylaminuria patient and one SIBO-patient reported a reduction of symptoms. Three patients did not experience a benefit from FMT: chronic norovirus, lymphocytic colitis and the other fish malodour syndrome. There were no reported side effects in this group. FMT appeared to be safe and effective for immunocompromised patients with r CDI. FMT showed promise for the eradication of antibiotic-resistant bacteria, but further research is warranted. | Perttu Lahtinen Eero Mattila Veli-Jukka Anttila Jyrki Tillonen Matti Teittinen Pasi Nevalainen Seppo Salminen Reetta Satokari Perttu Arkkila | 2017 | World Journal of Gastroenterology2017，23，39： | 2 |
| 2 | Time-resolved fluoroimmunoassay of human pancreatic phospholipase A2 显示文摘 | ESKOLA J U NEVALAINEN T J LOVGRENN T N | 1983 | Clinical Chemistry1983，29，10： | 1 |
| 3 | Epidemiology of intestinal and diffuse types of gastric carcinoma:a time-trend study in Finland with comparisonbetweenstudiesfromhigh-andlow-riskareas显示文摘 | Lauren P Nevalainen T | 1993 | Cancer1993，71，10： | 1 |
| 4 | Quantum chemical modeling of chiral catalysis, Part 4. On the hydride transfer in ketone complexes of borane adducts of oxazaborolidines and regeneration of catalyst显示文摘 | Nevalainen V | | 0，，： | 1 |
| 5 | Quantum chemical modeling of chiral catalysis, Part 8. On the conformational freedom of the ketone of ketone-borane complexes of oxazaborolidines used as catalysts in the enantioselective reduction of ketones显示文摘 | Nevalainen V | | 0，，： | 1 |
| 6 | Proliferation marker securin identifies favourable outcome in invasive duc-tal breast cancer显示文摘 | Talvinen K Tuikkala J Nevalainen O | | 0，，02： | 1 |
| 7 | Experimental pan- creatitis in the rat : sodium taurocholate-induced acute haem- orrhagic pancreatitis 显示文摘 | Aho HJ Koskensalo ML Nevalainen TJ | 1980 | Scand J Gastroenterol1980，15，4： | 1 |
| 8 | Optimization of the movements of a component placement machine显示文摘 | LEIP(A)L(A)T NEVALAINEN O | 1989 | European Journal of Operation Research1989，38，2： | 1 |
| 9 | Phospholipase A2 in acute pancreatitis显示文摘 | Nevalainen TJ | 1988 | Scand J Gastroenterol1988，23，8： | 1 |
| 10 | Quantum chemical modeling of chiral catalysis, Part 7. On the effects controlling the coordination of borane to chiral oxazaborolidines used as catalysts in the enantioselective reduction of ketones显示文摘 | Nevalainen V | | 0，，： | 1 |
| 11 | Experimental trends of NO in circulating fluidized bed combustion 显示文摘 | Tourunen A Saastamoinen J Nevalainen H | 2009 | Fuel2009，88，7： | 1 |
| 12 | Quantum chemical modeling of chiral catalysis, Part 12. On the influence of the nature of the ring system on binding in ketone-borane complexes of chiral oxazaborolidines used as catalysts in the enantioselective reduction of ketones显示文摘 | Nevalainen V | | 0，，： | 1 |
| 13 | Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists显示文摘 | Tremblay MR Nevalainen M Nair SJ | 2008 | J Med Chem2008，51，21： | 1 |
| 14 | Synthesis, Structure, Verification and Chromatographic Relative Retention Times for Polychlorinated Biphenyl Ethers 显示文摘 | Nevalainen T Koistinen J Nurmela P | 1994 | Envir on Sci Technol1994，28，： | 1 |
| 15 | Experimental acute pancreatitis in the rat: Sodium taurocholate-induced acute hemorrhagic pancreatitis显示文摘 | Aho HJ Koskensalo Sm-L Nevalainen TJ | 1980 | Scand J Gastroenterol1980，15，4： | 1 |
| 16 | Control ofplant-parasitic nematodes by Paecilomyces lilacinus andMonacrosporium lysipagum in pot trials显示文摘 | Khan A Willams K L Nevalainen H K M | 2006 | BioControl2006，51，： | 1 |
| 17 | Quantum chemical modeling of chiral catalysis, Part 19. Strain and stability-oxazadiboretanes potentially involved in the enantioselective reduction of ketones promoted by chiral oxazaborolidines显示文摘 | Nevalainen V | | 0，，： | 1 |
| 18 | Evaluating laboratoryperformance on quality indicators with the six scale 显示文摘 | Nevalainen D Berte L Kraft C | 2000 | Arch Pathol Lab Med2000，124，4： | 1 |
| 19 | Chlorophenanthrenes, alkylchlorophenanthrenes and alkylchloronaphthalenes in kraft pulp mill products and discharges 显示文摘 | KOISTINEN J PAASIVIRTA J NEVALAINEN T | 1994 | Chemosphere1994，28，： | 1 |
| 20 | Nasal Lavage Method in the Monitoring of Upper Airway Inflammation: Seasonal and Individual Variation显示文摘 | Koponen M Seurim Nevalainen A | 2003 | Inhal Toxicol2003，15，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员